Clinical characteristics of bipolar disorders with postpartum depressive onset.


Journal

Progress in neuro-psychopharmacology & biological psychiatry
ISSN: 1878-4216
Titre abrégé: Prog Neuropsychopharmacol Biol Psychiatry
Pays: England
ID NLM: 8211617

Informations de publication

Date de publication:
20 04 2021
Historique:
received: 18 08 2020
revised: 30 11 2020
accepted: 13 12 2020
pubmed: 22 12 2020
medline: 15 1 2022
entrez: 21 12 2020
Statut: ppublish

Résumé

Postpartum period is associated with an increased risk of bipolar disorder diagnosis and relapse, mainly major depressive episode. Onset during this period might be associated with specific characteristics. To compare the socio-demographic and clinical characteristics of parous women presenting with bipolar disorder and an index depressive episode occurring during or outside the postpartum period. Using the multicenter cohort FACE-BD (FondaMental Academic Centers of Expertise for Bipolar Disorders), we considered all women who started their BD with a major depressive episode and have at least one child. We compared two groups depending on the onset: in or outside the postpartum period. Among the 759 women who started BD with a major depressive episode, 93 (12.2%) had a postpartum onset, and 666 (87.8%) had not. Women who started BD in the postpartum period with a major depressive episode have a more stable family life, more children, an older age at onset, more Bipolar 2 disorder, less history of suicide attempts, less depressive episodes and more mood stabilizer treatments as compared to those who started with a major depressive episode outside the postpartum period. The multivariable logistic regression showed that women with an onset in the postpartum period had significantly more children, less lifetime depressive episodes and a lower rate of history of suicide attempts as compared to women with an onset outside the postpartum period. Our results suggest that women starting their BD with postpartum depression have a more favorable course of BD, especially less history of suicide attempt and less lifetime depressive episodes.

Sections du résumé

BACKGROUND
Postpartum period is associated with an increased risk of bipolar disorder diagnosis and relapse, mainly major depressive episode. Onset during this period might be associated with specific characteristics.
AIM
To compare the socio-demographic and clinical characteristics of parous women presenting with bipolar disorder and an index depressive episode occurring during or outside the postpartum period.
METHODS
Using the multicenter cohort FACE-BD (FondaMental Academic Centers of Expertise for Bipolar Disorders), we considered all women who started their BD with a major depressive episode and have at least one child. We compared two groups depending on the onset: in or outside the postpartum period.
RESULTS
Among the 759 women who started BD with a major depressive episode, 93 (12.2%) had a postpartum onset, and 666 (87.8%) had not. Women who started BD in the postpartum period with a major depressive episode have a more stable family life, more children, an older age at onset, more Bipolar 2 disorder, less history of suicide attempts, less depressive episodes and more mood stabilizer treatments as compared to those who started with a major depressive episode outside the postpartum period. The multivariable logistic regression showed that women with an onset in the postpartum period had significantly more children, less lifetime depressive episodes and a lower rate of history of suicide attempts as compared to women with an onset outside the postpartum period.
DISCUSSION
Our results suggest that women starting their BD with postpartum depression have a more favorable course of BD, especially less history of suicide attempt and less lifetime depressive episodes.

Identifiants

pubmed: 33347983
pii: S0278-5846(20)30541-8
doi: 10.1016/j.pnpbp.2020.110225
pii:
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

110225

Investigateurs

B Etain (B)
C Henry (C)
E Olié (E)
M Leboyer (M)
E Haffen (E)
P M Llorca (PM)
V Barteau (V)
S Bensalem (S)
O Godin (O)
H Laouamri (H)
K Souryis (K)
S Hotier (S)
A Pelletier (A)
N Drancourt (N)
J P Sanchez (JP)
E Saliou (E)
C Hebbache (C)
J Petrucci (J)
L Willaume (L)
E Bourdin (E)
F Bellivier (F)
M Carminati (M)
B Etain (B)
E Marlinge (E)
J Meheust (J)
B Antoniol (B)
A Desage (A)
S Gard (S)
A Jutant (A)
K Mbailara (K)
I Minois (I)
L Zanouy (L)
C Abettan (C)
L Bardin (L)
A Cazals (A)
P Courtet (P)
B Deffinis (B)
D Ducasse (D)
M Gachet (M)
A Henrion (A)
E Martinerie (E)
F Molière (F)
B Noisette (B)
E Olié (E)
G Tarquini (G)
J M Azorin (JM)
R Belzeaux (R)
N Correard (N)
J L Consoloni (JL)
F Groppi (F)
L Lescalier (L)
J Montant (J)
M Rebattu (M)
N Viglianese (N)
R Cohen (R)
J P Kahn (JP)
M Milazzo (M)
O Wajsbrot-Elgrabli (O)
T Bougerol (T)
B Fredembach (B)
A Suisse (A)
B Halili (B)
A Pouchon (A)
M Polosan (M)
A M Galliot (AM)
I Grévin (I)
A S Cannavo (AS)
N Kayser (N)
C Passerieux (C)
P Roux (P)
V Aubin (V)
I Cussac (I)
M A Dupont (MA)
J Loftus (J)
I Medecin (I)
C Dubertret (C)
N Mazer (N)
C Portalier (C)
C Scognamiglio (C)
A Bing (A)

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Sarah Tebeka (S)

AP-HP, Groupe Hospitalo-Universitaire AP-HP Nord, DMU ESPRIT, service de Psychiatrie et Addictologie, Hopital Louis Mourier, Colombes, Inserm U1266, Faculté de médecine, Université de Paris, France; Fondation Fondamental, Creteil 94000, France. Electronic address: Sarah.tebeka@aphp.fr.

Ophelia Godin (O)

Fondation Fondamental, Creteil 94000, France; Univ Paris Est Créteil, INSERM, IMRB, Translational Neuropsychiatry, Fondation FondaMental, F-94010, Créteil, France.

Nicolas Mazer (N)

AP-HP, Groupe Hospitalo-Universitaire AP-HP Nord, DMU ESPRIT, service de Psychiatrie et Addictologie, Hopital Louis Mourier, Colombes, Inserm U1266, Faculté de médecine, Université de Paris, France; Fondation Fondamental, Creteil 94000, France.

Frank Bellivier (F)

Fondation Fondamental, Creteil 94000, France; AP-HP, Groupe Hospitalo-Universitaire AP-HP Nord, DMU Neurosciences, GH Saint-Louis - Lariboisière - Fernand Widal, Centre Expert Troubles Bipolaires, INSERM UMRS 1144, Université de Paris, Paris, France.

Philippe Courtet (P)

Fondation Fondamental, Creteil 94000, France; PSNREC, Univ Montpellier, INSERM, CHU de Montpellier, Montpellier, France Department of Emergency Psychiatry and Acute Care, Lapeyronie Hospital, CHU Montpellier, Montpellier, France.

Bruno Etain (B)

Fondation Fondamental, Creteil 94000, France; AP-HP, Groupe Hospitalo-Universitaire AP-HP Nord, DMU Neurosciences, GH Saint-Louis - Lariboisière - Fernand Widal, Centre Expert Troubles Bipolaires, INSERM UMRS 1144, Université de Paris, Paris, France.

Sébastien Gard (S)

Fondation Fondamental, Creteil 94000, France; Centre de référence régional des pathologies anxieuses et de la dépression, Centre Expert dépression Résistante, Pôle de Psychiatrie générale et universitaire, CH Charles-Perrens, NutriNeuro (UMR INRAE 1286), Université de Bordeaux, Bordeaux, France.

Marion Leboyer (M)

Fondation Fondamental, Creteil 94000, France; Univ Paris Est Créteil, INSERM, IMRB, Translational Neuropsychiatry, Fondation FondaMental, F-94010, Créteil, France.

Pierre-Michel Llorca (PM)

Fondation Fondamental, Creteil 94000, France; Centre Hospitalier et Universitaire, Département de Psychiatrie, Université d'Auvergne, EA 7280, 63000 Clermont-Ferrand, France.

Joséphine Loftus (J)

Fondation Fondamental, Creteil 94000, France; Pôle de Psychiatrie, Centre Hospitalier Princesse Grace, Monaco, France.

Emilie Olié (E)

Fondation Fondamental, Creteil 94000, France; PSNREC, Univ Montpellier, INSERM, CHU de Montpellier, Montpellier, France Department of Emergency Psychiatry and Acute Care, Lapeyronie Hospital, CHU Montpellier, Montpellier, France.

Christine Passerieux (C)

Fondation Fondamental, Creteil 94000, France; Service Universitaire de Psychiatrie d'Adultes, Centre Hospitalier de Versailles, Le Chesnay, Université Paris-Saclay, UVSQ, Inserm, CESP, Team "DevPsy", 94807 Villejuif, France.

Mircea Polosan (M)

Fondation Fondamental, Creteil 94000, France; Université Grenoble Alpes, CHU de Grenoble et des Alpes, Grenoble Institut des Neurosciences (GIN) Inserm U1216, Grenoble, France.

Raymund Schwan (R)

Fondation Fondamental, Creteil 94000, France; Pôle Hospitalo-Universitaire de Psychiatrie et d'Addictologie du Grand Nancy Centre Psychothérapique de Nancy, Nancy France, Inserm U1114 Strasbourg France, Université de Lorraine Nancy, France.

Raoul Belzeaux (R)

Fondation Fondamental, Creteil 94000, France; Pôle de Psychiatrie, Assistance Publique Hôpitaux de Marseille, Marseille, France.

Caroline Dubertret (C)

AP-HP, Groupe Hospitalo-Universitaire AP-HP Nord, DMU ESPRIT, service de Psychiatrie et Addictologie, Hopital Louis Mourier, Colombes, Inserm U1266, Faculté de médecine, Université de Paris, France; Fondation Fondamental, Creteil 94000, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH